Daniel Offen

14.3k total citations · 4 hit papers
211 papers, 11.5k citations indexed

About

Daniel Offen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Daniel Offen has authored 211 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 86 papers in Cellular and Molecular Neuroscience and 55 papers in Neurology. Recurrent topics in Daniel Offen's work include Nerve injury and regeneration (50 papers), Parkinson's Disease Mechanisms and Treatments (35 papers) and Neurogenesis and neuroplasticity mechanisms (35 papers). Daniel Offen is often cited by papers focused on Nerve injury and regeneration (50 papers), Parkinson's Disease Mechanisms and Treatments (35 papers) and Neurogenesis and neuroplasticity mechanisms (35 papers). Daniel Offen collaborates with scholars based in Israel, United States and Sweden. Daniel Offen's co-authors include Eldad Melamed, Yossi Gilgun‐Sherki, Yael Barhum, Nirit Lev, Nisim Perets, E. Melamed, Ilan Ziv, Ari Barzilai, Tali Ben‐Zur and Ran Barzilay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Daniel Offen

210 papers receiving 11.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

2001 695 citations Yossi Gilgun‐Sherki, Eldad Melamed et al. profile →
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy

2004 513 citations Daniel Offen, Yossi Gilgun‐Sherki et al. profile →
Intranasal Delivery of Mesenchymal Stem Cell Derived Exosomes Loaded with Phosphatase and Tensin Homolog siRNA Repairs Complete Spinal Cord Injury

2019 345 citations Daniel Offen et al. profile →
Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders

2019 320 citations Daniel Offen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel Offen	5.4k	3.1k	2.5k	2.0k	1.4k	211	11.5k
Akiyoshi Kakita	4.2k 0.8×	3.0k 1.0×	5.4k 2.2×	1.6k 0.8×	2.2k 1.6×	439	12.3k
Juan Sanchez‐Ramos	2.8k 0.5×	2.6k 0.8×	2.8k 1.1×	2.4k 1.2×	760 0.6×	149	9.6k
Robert M. Friedlander	6.7k 1.2×	5.1k 1.7×	4.0k 1.6×	726 0.4×	1.8k 1.3×	215	14.7k
Eldad Melamed	3.7k 0.7×	4.5k 1.4×	6.0k 2.4×	1.3k 0.7×	1.5k 1.1×	228	13.6k
Kōji Abe	3.3k 0.6×	2.5k 0.8×	1.4k 0.6×	639 0.3×	1.8k 1.3×	390	9.1k
Naren L. Banik	5.6k 1.0×	2.9k 0.9×	1.4k 0.6×	575 0.3×	1.4k 1.0×	295	12.3k
Mathias Bähr	9.2k 1.7×	5.9k 1.9×	2.5k 1.0×	727 0.4×	1.7k 1.3×	356	17.3k
Lin Xie	4.3k 0.8×	3.3k 1.1×	888 0.4×	1.3k 0.7×	1.2k 0.9×	181	11.3k
Hideki Mochizuki	3.8k 0.7×	2.9k 0.9×	3.8k 1.5×	516 0.3×	1.8k 1.3×	436	11.4k
Josef Priller	4.9k 0.9×	2.7k 0.9×	1.7k 0.7×	1.1k 0.5×	2.4k 1.8×	212	18.0k

Countries citing papers authored by Daniel Offen

Since Specialization

Citations

This map shows the geographic impact of Daniel Offen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Offen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Offen more than expected).

Fields of papers citing papers by Daniel Offen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Offen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Offen. The network helps show where Daniel Offen may publish in the future.

Co-authorship network of co-authors of Daniel Offen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Offen. A scholar is included among the top collaborators of Daniel Offen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Offen. Daniel Offen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harel, Michal, et al.. (2025). Mesenchymal stem cell‐derived exosomes mitigate amyloid β‐induced retinal toxicity: Insights from rat model and cellular studies. Journal of Extracellular Biology. 4(1). e70024–e70024. 2 indexed citations

Shor, Oded, et al.. (2022). Computational normal mode analysis accurately replicates the activity and specificity profiles of CRISPR-Cas9 and high-fidelity variants. Computational and Structural Biotechnology Journal. 20. 2013–2019. 3 indexed citations

Abadi, Shiran, et al.. (2020). Prediction of synonymous corrections by the BE-FF computational tool expands the targeting scope of base editing. Nucleic Acids Research. 48(W1). W340–W347. 13 indexed citations

Stefanova, Nadia, et al.. (2020). Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy. Journal of Neural Transmission. 127(2). 205–212. 6 indexed citations

Golubchik, Pavel, et al.. (2018). Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 89. 90–96. 85 indexed citations

Benninger, Felix, Ravit Madar, Tomer Illouz, et al.. (2017). Toll‐like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE ‐induced epilepsy in mice. Epilepsia. 58(4). 586–596. 49 indexed citations

Petrou, Panayiota, Marc Gotkine, Yaël Gothelf, et al.. (2015). Autologous Transplantation of Mesenchymal Stem Cells Secreting Neurotrophic Factors (Nurown™) In ALS: Results of a Phase 2 Clinical Trial (P2.059). Neurology. 84(14_supplement). 2 indexed citations

Barhum, Yael, Tali Ben‐Zur, Tom Shani, et al.. (2015). A Chemical Chaperone‐Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS). ChemMedChem. 10(5). 850–861. 20 indexed citations

Benninger, Felix, et al.. (2014). The Role of Toll-Like Receptor 3 in Epileptogenesis (I1-2.001). Neurology. 82(10_supplement). 1 indexed citations

10.

Sadan, Ofer, Yael Barhum, Yossef S. Levy, et al.. (2009). Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease. Stem Cells and Development. 18(8). 1179–1190. 127 indexed citations

11.

Barzilay, Ran, Tali Ben‐Zur, Shlomo Bulvik, Eldad Melamed, & Daniel Offen. (2008). Lentiviral Delivery of LMX1a Enhances Dopaminergic Phenotype in Differentiated Human Bone Marrow Mesenchymal Stem Cells. Stem Cells and Development. 18(4). 591–602. 46 indexed citations

12.

Barzilay, Ran, et al.. (2008). Induction of Human Mesenchymal Stem Cells into Dopamine-Producing Cells with Different Differentiation Protocols. Stem Cells and Development. 17(3). 547–554. 72 indexed citations

13.

Offen, Daniel, Yael Barhum, Eldad Melamed, et al.. (2008). Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant. Journal of Molecular Neuroscience. 38(2). 85–93. 72 indexed citations

14.

Levy, Yossef S., Tali Ben‐Zur, Yael Barhum, et al.. (2006). Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition. Stem Cells and Development. 15(2). 141–164. 135 indexed citations

15.

Gilgun‐Sherki, Yossi, Hana Panet, Eldad Melamed, & Daniel Offen. (2003). Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Brain Research. 989(2). 196–204. 77 indexed citations

16.

Melamed, Eldad, et al.. (2002). Mutant and Wild-Type α-Synuclein Interact with Mitochondrial Cytochrome C Oxidase. Journal of Molecular Neuroscience. 18(3). 229–238. 92 indexed citations

17.

Offen, Daniel, et al.. (1998). Levodopa Toxicity and Apoptosis. Annals of Neurology. 44(S1). S149–54. 66 indexed citations

18.

Ziv, Ilan, Rina Zilkha‐Falb, Daniel Offen, et al.. (1997). Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease?. Movement Disorders. 12(1). 17–23. 79 indexed citations

19.

Ziv, I., Daniel Offen, Reuven Stein, et al.. (1997). The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's Disease. APOPTOSIS. 2(2). 149–155. 18 indexed citations

20.

Offen, Daniel, Ilan Ziv, Svetlana Gorodin, et al.. (1995). Dopamine-induced programmed cell death in mouse thymocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1268(2). 171–177. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact